Clinical trial No longer in our active list Observational Ages 20 to 60

MRI techniques for patients with hemifacial spasm

Official title: Clinical Research on Patients With Hemifacial Spasm by Multi-planar Reconstruction, Curved Planar Reconstruction and Magnetic Resonance Virtual Endoscopy

Run by First Affiliated Hospital Xi'an Jiaotong University · NCT04645277 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing new MRI techniques to see if they can better show the nerve and blood vessel issues in people with hemifacial spasm to help plan their surgery.

Quick facts

Study typeObservational
Ages20 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Academic / other
Locations1 site (Xi'an, Shaanxi)
Trial IDNCT04645277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with primary hemifacial spasm who have experienced unilateral facial muscle spasms for at least one year.

Probably not a fit

Patients with secondary causes of hemifacial spasm, such as tumors or cysts, or those with precarious health status may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of advanced magnetic resonance imaging techniques, specifically curved planar reconstruction and magnetic resonance virtual endoscopy, to better visualize neurovascular compressions in patients with hemifacial spasm. Traditional imaging methods may not adequately identify the details of these compressions, particularly when the vessels involved are veins rather than arteries. By employing three-dimensional analytic techniques, the study aims to enhance the sensitivity and specificity of imaging, which could assist in planning surgical interventions. The study focuses on patients with a history of unilateral facial muscle spasms lasting at least one year.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical planning and outcomes for patients suffering from hemifacial spasm.

How similar studies have gone: While traditional imaging methods have been widely used, the novel application of advanced three-dimensional techniques in this context is relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary HFS patients according to medical history and typical facial muscle spasms that are unilateral, involuntary, and had intermittent contractions innervated by the ipsilateral facial nerve. The patient has 1 year disease duration at least.

Exclusion Criteria:

* Secondary causes of HFS, such as tumors or cysts compressing the facial nerve in the cerebellar pontine cistern; Precarious general health status; Percutaneous lesions or surgical treatments; Cardiac pacemaker or metal implants.

Where it's running

  • The First Affiliated Hospital of Xi'an Jiaotong University
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

  • Principal investigator: Ming Zhang, M.D. & Ph.D. — First Affiliated Hospital Xi'an Jiaotong University
  • Study coordinator: Yuan Wang, M.D.
  • Email: wangyuan8003@126.com
  • Phone: 0086-13324598144

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.